Preclinical septic shock research: why we need an animal ICU
2019 · Annals of Intensive Care · 75 citations
https://doi.org/10.1186/s13613-019-0543-6
P
Peter Radermacher
Universität Ulm(DE)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
240
Papers
6.0K
Citations
37
h-index
84
i10-index
Peter Radermacher is an academic researcher from Universität Ulm. The author has contributed to research in topics: Respiratory Support and Mechanisms & Sepsis Diagnosis and Treatment & Cardiac Arrest and Resuscitation. The author has an h-index of 37, co-authored 204 publications.
Papers by this author
worksDesigning phase 3 sepsis trials: application of learned experiences from critical care trials in acute heart failure
2016 · Journal of Intensive Care · 58 citations
https://doi.org/10.1186/s40560-016-0151-6
Glucocorticoids coordinate macrophage metabolism through the regulation of the tricarboxylic acid cycle
2021 · Molecular Metabolism · 56 citations
https://doi.org/10.1016/j.molmet.2021.101424
Hyperoxia toxicity in septic shock patients according to the Sepsis-3 criteria: a post hoc analysis of the HYPER2S trial
2018 · Annals of Intensive Care · 47 citations
https://doi.org/10.1186/s13613-018-0435-1
The molecular fingerprint of lung inflammation after blunt chest trauma
2015 · European journal of medical research · 46 citations
https://doi.org/10.1186/s40001-015-0164-y
Hyperchloremia is not associated with AKI or death in septic shock patients: results of a post hoc analysis of the “HYPER2S” trial
2019 · Annals of Intensive Care · 35 citations
https://doi.org/10.1186/s13613-019-0570-3
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat